DUBLIN--(BUSINESS WIRE)--The "Orthobiologics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global orthobiologics market to grow with a CAGR of 5.5% over the forecast period of 2017-2023.
The report on global orthobiologics market provides qualitative and quantitative analysis for the period of 2015 to 2023.
The report on orthobiologics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global orthobiologics market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global orthobiologics market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Global Orthobiologics Market by Type
- Bone Morphogenic Proteins
- Demineralised Bone Matrix
- Synthetic Bone Grafts
- Joint Fluid Therapy (Viscosupplementation)
- Stem Cell Therapies
- Soft Tissue Repair
Global Orthobiologics Market by Application
- Spinal Fusion
- Trauma Repair
- Reconstructive Surgery
- Soft-Tissue Injuries
- Fracture Recovery
Global Orthobiologics Market by End-Use
- Dental Clinics And Facilities
- Research & Academic Institutes
- Zimmer Biomet Holdings, Inc.
- DePuy Synthes
- Stryker Corporation
- Harvest Technologies Corporation
- Globus Medical, Inc.
- Orthofix International N.V.
- Nuvasive, Inc.
- Bioventus LLC
- Kuros Biosciences Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/774lfx/orthobiologics?w=4